Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
24
Number of overlapping holdings
29.3%
% of AGNG's 82 holdings also in BMED
22.2%
% of BMED's 119 holdings also in AGNG
Overlap by Weight
Sector Drift (AGNG minus BMED)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in AGNG |
Weight in BMED |
Overlap | |
|---|---|---|---|---|
 |
BOSTON SCIENTIFIC CORP | 4.0% | 4.8% | 4.0% |
 |
ROCHE HOLDING AG-BR | 2.9% | 2.8% | 2.8% |
 |
UCB SA | 3.4% | 2.5% | 2.5% |
|
ABBVIE INC | 3.0% | 1.7% | 1.7% |
|
INSULET CORP | 1.7% | 1.8% | 1.7% |
Position Highlights (Non-Overlapping Exposures)
AGNG Overweight Relative to BMED
|
WELLTOWER, INC. | 4.0% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 3.6% |
|
ELI LILLY & CO | 3.1% |
 |
ASTRAZENECA PLC-SPONS ADR | 2.8% |
|
JOHNSON & JOHNSON | 2.8% |
 |
CELLTRION INC | 2.5% |
|
TERUMO CORP | 2.5% |
|
ALCON, INC. | 2.4% |
|
STRYKER CORP | 2.3% |
|
REGENERON PHARMACEUTICALS | 2.2% |
AGNG Underweight Relative to BMED
|
INTUITIVE SURGICAL INC | -5.1% |
|
ARGENX SE ADR | -3.6% |
|
GILEAD SCIENCES INC | -3.1% |
|
LONZA GROUP AG-REG | -2.6% |
|
ABBOTT LABORATORIES | -2.3% |
|
SAREPTA THERAPEUTICS INC | -2.1% |
|
BIO-TECHNE CORPORATION | -2.1% |
|
REPLIGEN CORP | -2.0% |
|
WATERS CORP | -2.0% |
|
DANAHER CORP | -1.8% |